Literature DB >> 8645943

The effect of thymectomy on myasthenia gravis, thrombocytopenia, and granulocytopenia associated with thymoma: report of a case.

M Kobayashi1, T Hasegawa, S Iwabuchi, M Fukushima, H Koie, K Kannari.   

Abstract

We report the case of a 47-year-old woman with thymoma who developed myasthenia gravis, thrombocytopenia, and granulocytopenia, simultaneously, the concurrent association of these four disorders being extremely rare. Thymectomy was performed, and, during the post-thymectomy course, there were surprising findings concerning the recovery of not only the myasthenia gravis but also of the hematologic disorders. Immediately after thymectomy, the myasthenic symptoms completely disappeared, and the granulocyte and platelet counts recovered to within the normal range within a few days. The laboratory data revealed no difference between pre- and post-thymectomy in the release of cytokines (tumor necrosis factor; TNF, interleukin; IL-2, and IL-6), anti-acetylcholine receptor antibody, or platelet-associated IgG. On the other hand, the serum level of anti-neutrophil cytoplasmic antibody (p-ANCA), against the myeloperoxidase of the granulocytes was dramatically decreased, after thymectomy, showing a significant correlation with the granulocyte count. According to our survey of the literature, this is the first report to show that the removal of a thymoma led to the dramatic resolution not only of myasthenia gravis but also of other associated diseases. It is possible that p-ANCA may be regulated by thymoma, thus causing severe granulocytopenia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8645943     DOI: 10.1007/bf00311695

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: immunobiological aspects.

Authors:  W L Gross; E Csernok; W H Schmitt
Journal:  Klin Wochenschr       Date:  1991-09-03

2.  Thymoma with agranulocytosis and hypogammaglobulinaemia.

Authors:  R H Young
Journal:  Ir J Med Sci       Date:  1977-08       Impact factor: 1.568

3.  Antibody-mediated pure neutrophil aplasia, recurrent myasthenia gravis and previous thymoma: case report and literature review.

Authors:  P W Mathieson; J H O'Neill; S T Durrant; S J Henderson; P J Green; J Newsom-Davis
Journal:  Q J Med       Date:  1990-01

4.  Response of agranulocytosis to thymectomy in a patient with thymoma and chronic lymphocytic leukemia.

Authors:  A B Weir; L W Dow
Journal:  Med Pediatr Oncol       Date:  1989

Review 5.  The spectrum of diseases associated with thymoma. Coincidence or syndrome?

Authors:  J V Souadjian; P Enriquez; M N Silverstein; J M Pépin
Journal:  Arch Intern Med       Date:  1974-08

6.  White blood cell aplasia associated with thymoma.

Authors:  S P Ackland; M E Bur; S S Adler; M Robertson; J M Baron
Journal:  Am J Clin Pathol       Date:  1988-02       Impact factor: 2.493

7.  Pure white-cell aplasia. Antibody-mediated autoimmune inhibition of granulopoiesis.

Authors:  L J Levitt; C A Ries; P L Greenberg
Journal:  N Engl J Med       Date:  1983-05-12       Impact factor: 91.245

8.  Imbalances in T-cell subpopulations in myasthenia gravis.

Authors:  H C Chiu; K H Hsieh; T P Hung
Journal:  J Neurol Sci       Date:  1981-10       Impact factor: 3.181

9.  Syndrome of neutrophil agranulocytosis, hypogammaglobulinemia, and thymoma.

Authors:  L Degos; A Faille; M Housset; L Boumsell; C Rabian; T Parames
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

10.  Myasthenia gravis and Werlhof's disease.

Authors:  W A Veenhoven; H J Oosterhuis; G S van der Schans
Journal:  Acta Med Scand       Date:  1979
View more
  1 in total

1.  Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature.

Authors:  Yasunori Miyamoto; Kouichi Hirayama; Hiroshi Maruyama; Kentaro Ohgi; Mamiko Takayasu; Homare Shimohata; Masaki Kobayashi
Journal:  BMC Nephrol       Date:  2019-04-08       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.